Article
Ethics of predictive DNA-testing for hereditary breast and ovarian cancer.
Patient education and counseling - 1 Sept 1998
de Wert G
Abstract excerpt
The recent identification of gene mutations involved in hereditary cancers increasingly allows for predictive DNA-testing. There is an urgent need to analyse the ethical issues involved. This article concentrates on the ethics of predictive testing for mutations in the breast (and ovarian) cancer genes BRCA1 and -2. Using international guidelines for presymptomatic DNA-testing for Huntington disease and the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
